Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.

Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
复制标题

DOI:
10.1093/infdis/jiw338
复制
发表时间:
2016-10-15
期刊:
The Journal of infectious diseases
影响因子:
--
通讯作者:
Parikh S
Parikh S
中科院分区:
其他
文献类型:
--
作者:
Tchaparian E;Sambol NC;Arinaitwe E;McCormack SA;Bigira V;Wanzira H;Muhindo M;Creek DJ;Sukumar N;Blessborn D;Tappero JW;Kakuru A;Bergqvist Y;Aweeka FT;Parikh S

文献摘要

参考文献

相似文献

背景:本芴醇是最广泛使用的疟疾治疗药物蒿甲醚-本芴醇的一种成分,其药代动力学和药效学尚未在幼儿中得到充分表征。 方法:在105名乌干达儿童中测定毛细血管全血本芴醇浓度和治疗结果,这些儿童年龄在6个月到2岁之间,他们用蒿甲醚-本芴醇治疗了249次恶性疟原虫疟疾。 结果:本芴醇的群体药代动力学采用一级吸收的二室开放模型。 在一个模型中,年龄与生物利用度有显着的正相关性,包括异速生长缩放。未接受甲氧苄啶-磺胺甲恶唑治疗的儿童,毛细血管全血浓度<200 ng/mL,与浓度>200 ng/mL的儿童相比,28天复发性寄生虫血症的风险高3倍(P = .0007)。然而,对于接受甲氧苄啶-磺胺甲恶唑治疗的儿童,在此阈值的基础上,复发性寄生虫血症的风险没有显著差异。第3天的浓度比第7天的浓度更能预测28天的复发。结论:我们证明,除体重外,年龄也是本芴醇暴露的决定因素,在没有甲氧苄啶-磺胺甲恶唑的情况下,本芴醇暴露是复发性寄生虫血症的决定因素。 6个月至2岁儿童的接触水平一般低于公布的年龄较大儿童和成人的接触水平。可能需要进一步改进蒿甲醚-苯芴醇的剂量,以改善婴儿和幼儿的暴露。
Background. The pharmacokinetics and pharmacodynamics of lumefantrine, a component of the most widely used treatment for malaria, artemether-lumefantrine, has not been adequately characterized in young children. Methods. Capillary whole-blood lumefantrine concentration and treatment outcomes were determined in 105 Ugandan children, ages 6 months to 2 years, who were treated for 249 episodes of Plasmodium falciparum malaria with artemether-lumefantrine. Results. Population pharmacokinetics for lumefantrine used a 2-compartment open model with first-order absorption. Age had a significant positive correlation with bioavailability in a model that included allometric scaling. Children not receiving trimethoprim-sulfamethoxazole with capillary whole blood concentrations <200 ng/mL had a 3-fold higher hazard of 28-day recurrent parasitemia, compared with those with concentrations >200 ng/mL (P = .0007). However, for children receiving trimethoprim-sulfamethoxazole, the risk of recurrent parasitemia did not differ significantly on the basis of this threshold. Day 3 concentrations were a stronger predictor of 28-day recurrence than day 7 concentrations. Conclusions. We demonstrate that age, in addition to weight, is a determinant of lumefantrine exposure, and in the absence of trimethoprim-sulfamethoxazole, lumefantrine exposure is a determinant of recurrent parasitemia. Exposure levels in children aged 6 months to 2 years was generally lower than levels published for older children and adults. Further refinement of artemether-lumefantrine dosing to improve exposure in infants and very young children may be warranted.
DOI: 10.1186/1475-2875-12-235
发表时间: 2013-07-10
期刊: Malaria journal
影响因子: 3
作者:
Staehli Hodel EM;Guidi M;Zanolari B;Mercier T;Duong S;Kabanywanyi AM;Ariey F;Buclin T;Beck HP;Decosterd LA;Olliaro P;Genton B;Csajka C
通讯作者: Csajka C
柬埔寨恶性疟原虫疟疾中的双氢青蒿素-哌喹抗药性:一项多地点前瞻性队列研究。
DOI: 10.1016/s1473-3099(15)00487-9
发表时间: 2016-03
期刊: The Lancet. Infectious diseases
影响因子: --
作者:
Amaratunga C;Lim P;Suon S;Sreng S;Mao S;Sopha C;Sam B;Dek D;Try V;Amato R;Blessborn D;Song L;Tullo GS;Fay MP;Anderson JM;Tarning J;Fairhurst RM
通讯作者: Fairhurst RM
DOI: 10.1111/j.1365-3156.2006.01784.x
发表时间: 2007-02-01
影响因子: 3.3
作者:
Ashley, Elizabeth A.;Stepniewska, Kasia;Nosten, Francois
通讯作者: Nosten, Francois
DOI: 10.1128/aac.05265-11
发表时间: 2011-12-01
影响因子: 4.9
作者:
Kredo, T.;Mauff, K.;Barnes, K. I.
通讯作者: Barnes, K. I.
DOI: 10.1186/s12936-015-1049-9
发表时间: 2016-01-05
期刊: MALARIA JOURNAL
影响因子: 3
作者:
Green, Michael;Otieno, Kephas;Desai, Meghna
通讯作者: Desai, Meghna